Literature DB >> 17703272

Variations along the 24-hour cycle of circulating osteoprotegerin and soluble RANKL: a rhythmometric analysis.

A Dovio1, D Generali, M Tampellini, A Berruti, S Tedoldi, M Torta, S Bonardi, M Tucci, G Allevi, S Aguggini, A Bottini, L Dogliotti, A Angeli.   

Abstract

UNLABELLED: The variability of serum osteoprotegerin (OPG) and soluble RANKL (sRANKL) along the 24-h cycle was assessed in 20 healthy women. No rhythmic variations of serum OPG, sRANKL or sRANKL/OPG ratio were detected as a group phenomenon. Timing of sampling is unlikely to influence the results of measurements of circulating OPG and sRANKL.
INTRODUCTION: Physiological bone turnover shows diurnal variations. The aim of the study was to assess variability of OPG and sRANKL serum levels along the 24-h cycle.
METHODS: Blood was collected from 20 healthy women (median age 31 years, range 25-65 years) at 4-h intervals between 08:00 and 24:00 and at 2-h intervals between 24:00 and 08:00. Serum albumin, cortisol, osteocalcin (OC), C-terminal telopeptide of type I collagen (CTX), OPG and total sRANKL were measured. Temporal variations were assessed by the COSINOR model.
RESULTS: Circadian rhythms of cortisol and albumin documented a normal synchronization within the circadian structure. Serum OC and CTX showed rhythmic variations, peaking at night-time. Rhythmic variations of serum OPG, sRANKL and sRANKL/OPG ratio were not detected as a group phenomenon. On an individual basis, rhythmic changes were detected in ten patients for OPG and eight patients for sRANKL, with very small amplitudes and heterogeneous acrophases.
CONCLUSIONS: The absence of consistent rhythmic variations of circulating OPG and sRANKL levels may reflect the absence of rhythmic variations of their expression in the bone microenvironment. Were this the case, the nocturnal rise of bone resorption should be accounted for by different, not RANKL/OPG-mediated factors. Since circulating OPG and sRANKL may derive from sources other than bone, rhythmicity could be masked by non-rhythmic or non-synchronized rhythmic expression in these sources. Timing of sampling is unlikely to influence the results of measurements of circulating OPG and sRANKL.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17703272     DOI: 10.1007/s00198-007-0423-z

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  24 in total

1.  Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting.

Authors:  P Qvist; S Christgau; B J Pedersen; A Schlemmer; C Christiansen
Journal:  Bone       Date:  2002-07       Impact factor: 4.398

Review 2.  RANK ligand.

Authors:  J M Blair; Y Zheng; C R Dunstan
Journal:  Int J Biochem Cell Biol       Date:  2006-11-23       Impact factor: 5.085

3.  Negative regulation of osteoclastogenesis by ectodomain shedding of receptor activator of NF-kappaB ligand.

Authors:  Atsuhiko Hikita; Ikuo Yana; Hidetoshi Wakeyama; Masaki Nakamura; Yuho Kadono; Yasushi Oshima; Kozo Nakamura; Motoharu Seiki; Sakae Tanaka
Journal:  J Biol Chem       Date:  2006-10-03       Impact factor: 5.157

4.  Characterization of monomeric and homodimeric forms of osteoclastogenesis inhibitory factor.

Authors:  A Tomoyasu; M Goto; N Fujise; S Mochizuki; H Yasuda; T Morinaga; E Tsuda; K Higashio
Journal:  Biochem Biophys Res Commun       Date:  1998-04-17       Impact factor: 3.575

5.  Circadian oscillation of gene expression in murine calvarial bone.

Authors:  Sanjin Zvonic; Andrey A Ptitsyn; Gail Kilroy; Xiying Wu; Steven A Conrad; L Keith Scott; Farshid Guilak; Gadi Pelled; Dan Gazit; Jeffrey M Gimble
Journal:  J Bone Miner Res       Date:  2007-03       Impact factor: 6.741

6.  Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines.

Authors:  T Nakashima; Y Kobayashi; S Yamasaki; A Kawakami; K Eguchi; H Sasaki; H Sakai
Journal:  Biochem Biophys Res Commun       Date:  2000-09-07       Impact factor: 3.575

7.  Increased osteoprotegerin levels in Cushing's syndrome are associated with an adverse cardiovascular risk profile.

Authors:  Andrea Dovio; Barbara Allasino; Enrico Palmas; Massimo Ventura; Anna Pia; Laura Saba; Emiliano Aroasio; Massimo Terzolo; Alberto Angeli
Journal:  J Clin Endocrinol Metab       Date:  2007-02-27       Impact factor: 5.958

8.  Disassociation of bone resorption and formation by GLP-2: a 14-day study in healthy postmenopausal women.

Authors:  Dennis B Henriksen; Peter Alexandersen; Bolette Hartmann; Charlotte L Adrian; Inger Byrjalsen; Henry G Bone; Jens J Holst; Claus Christiansen
Journal:  Bone       Date:  2006-11-01       Impact factor: 4.398

9.  Diurnal variation of bone mineral turnover in elderly men and women.

Authors:  S L Greenspan; R Dresner-Pollak; R A Parker; D London; L Ferguson
Journal:  Calcif Tissue Int       Date:  1997-05       Impact factor: 4.333

Review 10.  Circulating osteoprotegerin and soluble RANKL: do they have a future in clinical practice?

Authors:  A Dovio; V Data; A Angeli
Journal:  J Endocrinol Invest       Date:  2005       Impact factor: 4.256

View more
  10 in total

1.  Osteoprotegerin and fractures in men and women with chronic kidney disease.

Authors:  Sarah L West; Charmaine E Lok; Sophie A Jamal
Journal:  J Bone Miner Metab       Date:  2014-07       Impact factor: 2.626

Review 2.  Obstructive sleep apnea and metabolic bone disease: insights into the relationship between bone and sleep.

Authors:  Christine M Swanson; Steven A Shea; Katie L Stone; Jane A Cauley; Clifford J Rosen; Susan Redline; Gerard Karsenty; Eric S Orwoll
Journal:  J Bone Miner Res       Date:  2015-02       Impact factor: 6.741

Review 3.  Circadian rhythms in gene expression: Relationship to physiology, disease, drug disposition and drug action.

Authors:  Siddharth Sukumaran; Richard R Almon; Debra C DuBois; William J Jusko
Journal:  Adv Drug Deliv Rev       Date:  2010-06-11       Impact factor: 15.470

Review 4.  The importance of the circadian system & sleep for bone health.

Authors:  Christine M Swanson; Wendy M Kohrt; Orfeu M Buxton; Carol A Everson; Kenneth P Wright; Eric S Orwoll; Steven A Shea
Journal:  Metabolism       Date:  2017-12-09       Impact factor: 8.694

5.  24-hour profile of serum sclerostin and its association with bone biomarkers in men.

Authors:  C Swanson; S A Shea; P Wolfe; S Markwardt; S W Cain; M Munch; C A Czeisler; E S Orwoll; O M Buxton
Journal:  Osteoporos Int       Date:  2017-07-26       Impact factor: 4.507

Review 6.  A Systematic Review of the Circadian Rhythm of Bone Markers in Blood.

Authors:  Sarah Seberg Diemar; Stig Søgaard Dahl; Anders Sode West; Sofie Amalie Simonsen; Helle Klingenberg Iversen; Niklas Rye Jørgensen
Journal:  Calcif Tissue Int       Date:  2022-03-19       Impact factor: 4.333

7.  Secretion patterns of circulating osteoprotegerin and response to acute and chronic energy deprivation in young healthy adults.

Authors:  Konstantinos N Aronis; Joo-Pin Foo; John P Chamberland; Christos S Mantzoros
Journal:  J Clin Endocrinol Metab       Date:  2012-05-04       Impact factor: 5.958

Review 8.  Distinct Glucocorticoid Receptor Actions in Bone Homeostasis and Bone Diseases.

Authors:  Sooyeon Lee; Benjamin Thilo Krüger; Anita Ignatius; Jan Tuckermann
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-10       Impact factor: 5.555

Review 9.  The role of circadian rhythm in osteoporosis; a review.

Authors:  Yihao Tian; Jian Ming
Journal:  Front Cell Dev Biol       Date:  2022-09-27

Review 10.  Insights into the Role of Circadian Rhythms in Bone Metabolism: A Promising Intervention Target?

Authors:  Chao Song; Jia Wang; Brett Kim; Chanyi Lu; Zheng Zhang; Huiyong Liu; Honglei Kang; Yunlong Sun; Hanfeng Guan; Zhong Fang; Feng Li
Journal:  Biomed Res Int       Date:  2018-09-27       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.